Circulation

NOVEMBER 11, 2024

17.4]) and was also more likely to have diabetes mellitus, hyperlipidemia, chronic lung disease, chronic kidney disease, chronic liver disease, BMI ≥ 25, anemia, metastatic cancer, and atrial fibrillation. The hemophilia cohort was slightly older (63.2[16.8]

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40

Dr. Paddy Barrett

FEBRUARY 13, 2024

Even in diabetics of normal weight (BMI<27), weight loss can reverse diabetes 2. The world we live in means you are massively incentivised to eat in a way that makes you gain excess weight that will likely result in metabolic dysfunction and an increased risk of not only heart disease but many cancers and also dementia.

Diet 103

Diet Diabetes Exercise Kidney Disease 103

Physiologically Speaking

JANUARY 26, 2024

COSMOS tested a cocoa extract supplement and a multivitamin-mineral supplement against one another and a placebo for reducing the risk of cardiovascular disease and cancer. This hypothesis was studied in a randomized controlled trial known as the COcoa Supplement and Multivitamin Outcomes Study or COSMOS.

Physiology 52

Physiology Diet Cardiovascular Disease BMI 52

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

LH individuals also appear to have more cardiovascular disease (CVD) related conditions like diabetes and cancer. FMD was significantly ( p  = 0.043) lower in LH (6.1% ± 3.2%) compared to RH (7.6% ± 3.8%), independent of age, sex, race, BMI, and HDL. Additionally, SDNN was lower ( p  = 0.041) in LH (47.4 ± 18.8 ms)

Cardiovascular Disease 109

Cardiovascular Disease BMI Laboratory Cancer 109

DAIC

MARCH 8, 2024

The estimated relative risk reduction of MACE was 20% vs placebo (HR 0.80 [95% CI: 0.72, 0.90] p 1,2 The reduction of MACE with Wegovy was not impacted by age, sex, race, ethnicity, baseline BMI, or level of renal function impairment. These may be symptoms of thyroid cancer. in patients randomized to Wegovy 2.4 mg and 36.4%

Obesity 111

Obesity Heart Disease Heart Attack Heart attacks 111

DAIC

FEBRUARY 1, 2024

QRISK incorporates factors such as blood pressure, cholesterol, BMI, smoking status, age, sex, and family history to estimate risk. About PRS Genetics is an important risk factor for many common diseases like CVD, and others including diabetes, osteoporosis, and common cancers like breast , prostate , and bowel cancer.

Cardiovascular Disease 110

Cardiovascular Disease Risk Factors Best Practices Cholesterol 110

DAIC

MARCH 5, 2024

They adjusted for the participants' use of tobacco and other characteristics, including their age, sex, race, body mass index or BMI, obesity, diabetes, physical activity levels, and socioeconomic status. For a more complete funding disclosure and list of authors, please see the full JAHA research article.

Heart Attack 98

Heart Attack Heart attacks Strokes Stroke 98

Frontiers in Cardiovascular Medicine

DECEMBER 15, 2024

Osimertinib is first-line treatment for epidermal growth factor (EGFR)-mutated non-small cell lung cancer (NSCLC) and has been associated with cardiotoxicity. BMI was identified as a potentially modifiable risk factor for osimertinib-associated cardiotoxicity, worthy of further study. Following osimertinib (vs. vs. 5.3%; p=.046).

Cancer 52

Cancer Electrocardiogram BMI Risk Factors 52